Protection of Stratospheric Ozone: Phaseout of Chlorobromomethane Production and Consumption

Note: EPA no longer updates this information, but it may be useful as a reference or resource.

[Federal Register: July 18, 2003 (Volume 68, Number 138)]
[Rules and Regulations]
[Page 42883-42895]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr18jy03-29]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 82
[FRL-7529-4]
RIN 2060-AJ27

Protection of Stratospheric Ozone: Phaseout of Chlorobromomethane
Production and Consumption

AGENCY: Environmental Protection Agency (EPA).
ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Montreal Protocol on Substances that
Deplete the Ozone Layer (Protocol), EPA is adding chlorobromomethane
(CBM) to the list of substances subject to production and consumption
controls under the Clean Air Act (CAA) and EPA's implementing
regulations. Today's action creates a new Group (Group VIII) of class I
substances for CBM, and designates the value of CBM's ``ozone depleting
potential'' (ODP) as 0.12. In accordance with the Protocol, today's
action will phase out CBM production and consumption upon publication
of this rule with permitted exemptions. Today's action also restricts
trade in CBM with countries who are not Parties to the Beijing
Amendments to the Protocol. EPA received no comments on the Notice of
Proposed Rulemaking (NPRM) during the comment period between October
29, 2002 and November 29, 2002.

DATES: This rule is effective on August 18, 2003.

ADDRESSES: Materials relevant to this rulemaking are contained in
Public Docket No. A-92-13, Section XII. The docket is located at U.S.
Environmental Protection Agency, EPA West (Air Docket), 1301
Constitution Avenue, NW., Room: B108, Mail Code 6102T, Washington, DC
20004. The materials may be inspected from 8 am until 5:30 pm, Monday
through Friday. The telephone number is (202) 566-1742. The fax number
is (202) 566-1741. The docket may charge a reasonable fee for copying
docket materials.

FOR FURTHER INFORMATION CONTACT: The Stratospheric Ozone Information
Hotline at 1-800-296-1996, or Jabeen Akhtar, U.S. Environmental
Protection Agency, Global Programs Division (6205J), 1200 Pennsylvania
Avenue, NW., Washington, DC, 20460, (202) 564-3514;
akhtar.jabeen@epa.gov. You may also visit the Ozone Depletion Web site
of EPA's Global Programs Division at http://www.epa.gov/ozone/index.html
for further information about EPA's Ozone Protection
regulations, the science of ozone depletion, and other topics.

SUPPLEMENTARY INFORMATION: This document concerns amendments to the
production and import controls for ozone-depleting substances (ODS).
The amendment concerns the addition of a new controlled substance,
chlorobromomethane (CBM), to the list of substances already subject to
controls related to production, import, export, destruction,
transhipment, essential uses, and feedstock uses.
The regulated categories that may be affected by this action
include:

----------------------------------------------------------------------------------------------------------------
Examples of potentially regulated
Category SIC NAICS entities
----------------------------------------------------------------------------------------------------------------
1. Industrial organic chemicals, 2869..................... 325199 Producers, importers, or exporters of
NEC. CBM.
2. Pharmaceutical preparations... 2834..................... 325412 Transformers of CBM.
3. Pesticides and agricultural 2879..................... 32532 Transformers of CBM.
chemicals, NEC.
4. Chemicals and allied products, 5169..................... 42269 Lab suppliers of CBM.
NEC.
5. Testing laboratories, except 8734..................... 54138 Lab users of CBM.
veterinary testing labs.
6. Medical and diagnostic 8071..................... 6215 Lab users of CBM.
laboratories.
7. Research and development in 8731..................... 54171 Lab users of CBM.
the physical, engineering and and 8733.................
life sciences.
----------------------------------------------------------------------------------------------------------------

This table is not intended to be exhaustive, but rather provides a
guide for readers regarding entities likely to be regulated by this
action. This table lists the types of entities that EPA is now aware
could potentially be regulated by this action. Other types of entities
not listed in this table could also be affected. To determine whether
your facility, company, business organization, etc., could be regulated
by this action, you should carefully examine the applicability criteria
in Sec. 82.1(b) of Title 40 of the Code of Federal Regulations (CFR).
If you have any questions regarding the applicability of this action to
a particular entity, consult the person listed in the FOR FURTHER
INFORMATION CONTACT section.

Table of Contents

I. What Is the Scientific and Legal Background for the Regulations
to Phase Out Ozone-Depleting Substances?
II. What Chemicals Are Addressed by Today's Action and How Are They
Used?
III. What Are the Elements of the International Agreement To
Regulate CBM?
IV. What New U.S. Requirements Will Today's Action Impose?
A. Legal Authority
B. Specific Elements of Today's Action
1. Listing CBM and Controls
2. Ban on Trade With Non-Parties
3. Laboratory Essential Use Exemption
4. Process Agents
5. Recordkeeping and Reporting Requirements
(a) Producers
(b) Importers
(c) Exporters
(d) Destroyers
(e) Transformers
(f) Transhipments and Heels
(g) Laboratory Essential Uses
V. What Other Stratospheric Protection Regulations Will Relate to
CBM Following Today's Action?
VI. Statutory and Executive Order Reviews
A. Executive Order 12866: Regulatory Planning and Review
B. Paperwork Reduction Act
C. Regulatory Flexibility Act
D. Unfunded Mandates Reform Act
E. Executive Order 13132: Federalism
F. Executive Order 13175: Consultation and Coordination with
Indian Tribal Governments
G. Executive Order 13045: Protection of Children from
Environmental Health & Safety Risks
H. Executive Order 13211: Actions that Significantly Affect
Energy Supply, Distribution, or Use
I. National Technology Transfer Advancement Act
J. Congressional Review Act

I. What Is the Scientific and Legal Background for Regulations To Phase
Out Ozone-Depleting Substances?

In response to the body of evidence linking chlorofluorocarbons
(CFCs) and other chlorinated and brominated compounds to ozone
depletion, the international community reached agreement in 1987 on a
landmark treaty. This treaty, the Montreal Protocol on Substances that
Deplete the Ozone

[[Page 42885]]

Layer (``Montreal Protocol'' or ``Protocol'') was signed by the United
States and ratified on April 4, 1988. The Protocol establishes controls
on the production and consumption of ozone depleting chemicals.
In the context of the regulatory program, the use of the term
consumption may be misleading. Consumption does not mean the ``use'' of
a controlled substance, but rather is defined as the formula:
consumption = production + imports -exports, of controlled substances
(Article 1 of the Protocol and section 601 of the CAA).
The Clean Air Act Amendments of 1990 direct the EPA to issue
regulations to implement the provisions of the Protocol within the
United States. Accordingly, EPA developed a scheme of production and
consumption controls relative to substances addressed by the Protocol.
The current regulatory requirements of the Stratospheric Ozone
Protection Program implement the provisions of the Protocol and the
Clean Air Act (CAA) by limiting the production and consumption of
ozone-depleting substances. These regulatory requirements are codified
at subpart A to part 82 of Volume 40 of the Code of Federal Regulations
(40 CFR part 82, subpart A). As the control measures of the Protocol
have been amended or adjusted, and in consideration of other factors,
subpart A has also been amended. For example, following the amendments
to the Protocol made at the Fourth Meeting of the Parties in Copenhagen
in 1992, a number of changes to the control provisions of subpart A to
40 CFR part 82 were made, including an accelerated phaseout of ODS
production and consumption. EPA published a final regulation in
December of 1993, implementing the United States' obligation under the
Copenhagen amendments (58 FR 65018). Other regulations amending Subpart
A include those published on December 20, 1994 (59 FR 65478), May 10,
1995 (60 FR 24970), August 4, 1998 (63 FR 41625), and October 5, 1998
(64 FR 53290).
Although the regulations phased out the production and consumption
of class I, Group II substances (halons) on January 1, 1994, and all
other class I controlled substances (except methyl bromide) on January
1, 1996, a very limited number of exemptions exist, consistent with
U.S. obligations under the Protocol. The regulations allow for the
manufacture of phased-out class I controlled substances, provided the
substances are either transformed, or destroyed (40 CFR 82.4(b)). They
also allow limited manufacture if the substances are (1) exported to
countries operating under Article 5 of the Protocol or (2) produced for
essential uses as authorized by the Protocol and the regulations.
Limited exceptions to the ban on the import of phased-out class I
controlled substances also exist if the substances are: (1) Previously
used, (2) imported for essential uses as authorized by the Protocol and
40 CFR part 82, subpart A, (3) imported for destruction or
transformation only, or (4) a transhipment (i.e., from one foreign
country through the U.S., to another foreign country) or a heel (a
small amount of controlled substance remaining in a container after
discharge) (40 CFR 82.4(d), 82.13(g)(2)).

II. What Chemicals Are Addressed by Today's Action and How Are They
Used?

Today's action will affect only one chemical, chlorobromomethane
(CBM).\1\ CBM is a chemical compound found in trace quantities in the
atmosphere with both natural and man-made sources. The Parties to the
Montreal Protocol designated the ozone-depleting potential of CBM as
0.12. This value is consistent with an examination of scientific
investigations on this topic, which concluded that an appropriate range
for the ODP of CBM is 0.07--0.15 (See 64 FR 22985, 4/18/99).
---------------------------------------------------------------------------

\1\ The terms chlorobromomethane and bromochloromethane are
synonymous. They both refer to the chemical, CH₂BrCl.
Both terms can be found in industry, scientific, and regulatory
documents.
---------------------------------------------------------------------------

The uses of CBM are described in the NPRM published in the Federal
Register on October 29, 2002 (67 FR 65916).

III. What Are the Elements of the International Agreement To Regulate
CBM?

The NPRM (67 FR 65916, 10/29/02) discussed the Parties' preliminary
consideration of CBM as an ozone depleting substance as well as the
provisions adopted at the Parties' meeting in Beijing in 1999.

IV. What Are the New U.S. Requirements Imposed by Today's Action?

A. Legal Authority

Several provisions of the CAA provide the legal authority for
today's action. Section 602(a) provides EPA with the general authority
to list Class I substances. Section 602(a) requires EPA to add to the
list of Class I substances those substances that it finds cause or
contribute significantly to harmful effects on the stratospheric ozone
layer. Section 602(a) also requires the listing of new substances,
pursuant to subsection 602(c), that have an ozone-depleting potential
of 0.2 or greater. Section 602(c) requires that the Administrator place
newly added Class I substances, to the extent consistent with the
Montreal Protocol, either into an existing Group or a new Group.
Whenever EPA adds a substance to the Class I list, EPA is also required
by section 602(e) to assign a numerical value representing the
substance's ozone-depleting potential (ODP). Section 602(e) requires
this ODP numerical value to be consistent with the Montreal Protocol if
such ODP is specified by the Montreal Protocol.
Those substances listed as a Class I (or Class II) substance are
then subject to the monitoring and reporting requirements as set forth
and implemented under section 603. Section 603(b) requires that on a
quarterly basis, or other such basis as EPA may prescribe, a report be
filed with EPA regarding the amount of substance(s) produced, imported,
and exported during the preceding reporting period.
Section 604 sets forth the general phase-out schedule of Class I
substances and exceptions to the phase-out. Section 604(a) requires EPA
to promulgate regulations implementing the phase-out schedule for Class
I substances set forth in the CAA. The section 604 phaseout date for
most Class I substances is January 1, 2000; however, under section
602(d), EPA may establish a later phaseout date for a newly listed
substance if the section 604 phaseout date is unattainable, considering
when the substance is listed.
Section 614(b) requires that Title VI of the CAA be ``construed,
interpreted, and applied as a supplement to the terms and conditions of
the Montreal Protocol, * * *, and shall not be construed, interpreted,
or applied to abrogate the responsibilities of the United States to
implement fully the provisions of the Montreal Protocol.'' Section
614(b) requires that in the case of any conflict ``between any
provision of this title and any provision of the Montreal Protocol, the
more stringent provision shall govern.'' Thus, today's actions list CBM
and put in place the phaseout controls consistent with the Montreal
Protocol.

B. Specific Elements of Today's Action

EPA received no comments in response to the actions proposed in the
NPRM (67 FR 65916, 10/29/02). Therefore, EPA is finalizing these
actions as they were proposed.
The effective date for all of today's actions will be 30 days from
the date of publication of today's rule in the

[[Page 42886]]

Federal Register. Under section 604(b) of the CAA, unless otherwise
stated, the phaseout date for Class I substances is January 1, 2000.
However, pursuant to section 602(d), EPA may establish a later phaseout
date for a newly listed substance if the section 604(b) date is
unattainable. Because the January 1, 2000 phaseout date is in the past,
it is unattainable. Therefore, EPA is establishing a later phaseout
date linked to the publication date of the final rule.
Today's effective date takes into consideration that the Beijing
Amendments entered-into-force under the Protocol on February 25, 2002,
for Parties that have ratified the amendment package. The U.S. Senate
gave their advice and consent to the ratification of the Beijing
Amendment package on October 9, 2002, but the U.S. must still
officially deposit its instrument of ratification with the United
Nations. Ninety days following the date the U.S. officially deposits
the instrument of ratification for the Beijing Amendment package, the
U.S. assumes obligations to comply with the provisions of the Beijing
Amendment. Thus, EPA needs to have put in place (prior to the deposit
of the instrument of ratification) final regulatory programs that will
implement and ensure U.S. compliance with the provisions of the Beijing
Amendment package.
1. Listing CBM and Controls
Today's action creates a new Group (Group VIII) of class I
substances, places CBM in this new Group, and assigns CBM an ODP of
0.12. Today's action establishes a full ban on CBM production and
import. This ban does not apply to the production or import of CBM that
is subsequently transformed or destroyed, or to imports of
transhipments or heels (see section I). There are no interim phasedown
levels; that is, production and import are unrestricted until 30 days
after publication of this rule.
Today's action does not allow production for the ``basic domestic
needs'' of Article 5 countries for reasons described in section III B
of the NPRM (67 FR 65916, 10/29/02).
If there is a need for CBM for laboratory and analytical uses after
the phaseout, a framework exists to allow the inclusion of CBM in the
production and import exemption for laboratory and analytical uses,
described in greater detail in section IV.B.3 of this Preamble.
2. Ban on Trade with Non-Parties
Today's action also prohibits CBM import from and export to a
foreign state that is not a Party to the 1999 Beijing Amendments to the
Protocol. In accordance with previously established provisions under
the Protocol, current EPA regulations (60 FR 24970; 40 CFR 82.4(l))
prohibit certain class I controlled substances from export to or import
from foreign states not Parties to the Montreal Protocol or specific
amendment packages to the Protocol (e.g., the London Amendments). With
today's action, EPA is adding a new subparagraph, Sec. 82.4(l)(5)
regarding a CBM trade ban that will become effective 30 days after the
date of publication of today's rule in the Federal Register.
A list of Parties that have ratified the Montreal Protocol and
successive amendments to the Protocol is published as Annex 1 in
appendix C to subpart A with today's final action. For the purposes of
the trade ban in today's action, companies should refer to appendix C
to subpart A of part 82 to identify nations that have not yet ratified
the Beijing Amendments. CBM imports from or exports to these nations
that have not ratified the Beijing Amendments are prohibited. EPA will
publish notices on a periodic basis to update this list (appendix C) to
reflect when Parties ratify the Montreal Protocol and its amendments.
For additional information on countries that have ratified the Protocol
and its amendments, visit the website of the United Nations Environment
Program (UNEP) Ozone Secretariat at www.unep.org/ozone/
and look for the ``Status of Ratification.''

3. Laboratory Essential Use Exemption
Article 21 of the Montreal Protocol allows for the possibility of
``essential use'' exemptions from the phaseout established for CBM. The
Parties have set up a framework for exempting phased out ozone-
depleting substances for laboratory and analytical uses under the
context of the essential use exemption. EPA has also provided a de
minimis exemption for essential laboratory uses of class I ODSs. The
criteria identifying exempt applications are specified in appendix G to
40 CFR part 82, subpart A.
The existing framework for exempting laboratory and analytical uses
is found in the criteria listed in appendix G of subpart A of 40 CFR
part 82. Entities wishing to use the exemption for laboratory and
analytical uses for CBM should refer to this criteria, which include
purity standards, containment requirements, and recycling and disposal
requirements for the substance. No prior approval is needed to use the
exemption for continued production and import of CBM, as long as the
criteria listed in appendix G of subpart A of 40 CFR part 82 are met
and the recordkeeping and reporting requirements specified in 40 CFR
82.13 (v) to (z) of subpart A, which are summarized later in this
Preamble, are followed. For further information about the essential use
exemption, you may refer to the NPRM (67 FR 65916, 10/29/02).
On February 11, 2002, EPA extended the exemption for laboratory and
analytical uses through the year 2005, while eliminating the following
uses, consistent with Decision XI/15: (a) Testing of oil, grease and
total petroleum hydrocarbons in water; (b) Testing of tar in road-
paving materials; and (c) Forensic finger-printing (67 FR 6352).
However, it should be noted that the Parties to the Montreal Protocol
have not extended the global laboratory and analytical essential-use
exemption indefinitely. This issue is further discussed at 66 FR 14767
(3/13/01).
4. Process Agents
Controlled substances produced or imported as process agents are
listed in table A of Decision X/14 of the Meetings of the Parties to
the Montreal Protocol. Parties may propose additions to the list of
controlled substances designated as process agents by sending a
detailed proposal to the Ozone Secretariat, which will forward them to
the Technology and Economic Assessment Panel (TEAP). The Panel will
then investigate the proposed change and make a recommendation to the
Parties whether or not the proposed use should be added to the list by
decision of the Parties.
In advance of publication of the NPRM (67 FR 65916, 10/29/02), EPA
received a letter from one stakeholder requesting that their use of CBM
as a solvent in the process of producing a polymer additive be
considered a process agent use. Based on information in this letter,
EPA determined this company's use of CBM to be exempt from restrictions
on controlled substances in 40 CFR part 82, subpart A. EPA submitted a
request to the Parties to the Protocol to add this use of CBM to the
list of process agents in Table A of Decision X/14 and to change the
emissions limit for the United States in Table B to reflect this
addition. The TEAP considered this U.S. request regarding the process
agent use of CBM and recommended to the Parties its inclusion in Table
A of Decision X/14. The Parties are expected to act on the U.S. request
during their meeting in the fall of 2003.

[[Page 42887]]

5. Recordkeeping and Reporting Requirements
With the designation of CBM as a class I ODS, existing
recordkeeping and reporting requirements in 40 CFR 82.13 will apply to
production, importation, destruction, transformation, transhipments,
export, or essential uses of CBM. Potentially affected parties are
urged to consult the relevant regulatory paragraphs in 40 CFR 82.13,
subpart A. In addition, guidance and reporting forms for these
requirements are available from EPA's Stratospheric Ozone Hotline
((800) 296-1996).
(a) Producers
Entities that produce CBM, as for other class I controlled
substances, must submit a report to the EPA Administrator within 120
days of publication of this rule, describing in detail how daily
production quantities are measured and recorded, including how fugitive
losses are accounted for and the estimated percent efficiency of the
production process. These entities must also maintain detailed records
pertaining to (i) the quantity of controlled substances produced at
each facility and the purposes for which they are produced, used, and
sold, with certain written verifications; (ii) quantities of other
chemicals produced within each facility and quantities of inputs used
in the production of controlled substances; and (iii) shipments of
controlled substances produced at each facility. These entities must,
in addition, submit a quarterly report identifying quarterly production
amounts and amounts sold, transferred, or exported (and specifying
amounts transformed or destroyed by the producer or recipient), with
appropriate verifications; and a list of the essential-use (including
laboratory essential use) allowance holders from whom orders were
placed and the quantity of essential-use controlled substances
requested and produced, with appropriate verifications. See 40 CFR part
82, subpart A (Sec. 82.13) for the complete reporting and
recordkeeping requirements.
(b) Importers
According to EPA's existing requirements for ODSs, a person may
import a used class I controlled substance if they comply with the
petition process described in 40 CFR 82.4(j), 40 CFR 82.13(g)(2), and
(3), and the revisions to this process published in a final rule in the
Federal Register on December 31, 2002 (67 FR 79861), entitled
``Protection of Stratospheric Ozone: Additional Reconsideration of
Petition Criteria and Incorporation of Montreal Protocol Decisions.''
Under the Protocol and the CAA, the import of ``used controlled
substances'' does not count against a country's obligation to
completely phase out import. Therefore, with the listing of CBM as a
class I controlled substance, an importer of used, recycled, or
reclaimed CBM is subject to the requirements specified in these
sections. Specifically, importers of used, recycled, or reclaimed
controlled substances and transshipments would need to fulfill the
import petition process.
The revised petition process for Class I substances (67 FR 79861,
12/31/02) now requires that for each individual shipment of greater
than five lbs, at least 40 working days before the shipment leaves the
foreign port of export, the importer must submit to EPA a petition
including the identity and quantity of the controlled substance;
information pertaining to the source, foreign owner, and exporter of
the controlled substance, information regarding the previous use and
identity of any domestic or foreign reclaimer; information on the
equipment from which the substance was recovered at each source,
information on import port of entry, vessel, and dates of shipment; the
intended use of the controlled substance, an export license from the
appropriate government agency in the country of export, and
certification of the accuracy of the information included in the
petition.
Entities that import CBM are also subject to the standard
recordkeeping and reporting requirements for importers of class I
substances. These include the requirement to maintain detailed records
of the quantity of each controlled substance, including information and
documentation pertaining to the amounts that may be in mixtures, that
are used, recycled or reclaimed, that are for use or sold for use in
processing resulting in their transformation or destruction, and that
are imported for essential uses; and including documentation and/or
certification relating to port of entry, country from which the
substance was imported, bill of lading, the U.S. customs entry form,
and intended use of the imported substance. Such entities must also
submit to EPA a quarterly report summarizing the records described
above and including certifications regarding the intended use of
controlled substances (e.g., transformation, destruction, essential
uses). In the case of imports of used (including recycled or reclaimed)
controlled substances, or heels of controlled substances, bills of
lading or invoices must be labeled, indicating that the controlled
substance is used, recycled, reclaimed, or a heel, as appropriate. See
40 CFR part 82, subpart A (Sec. 82.13) for complete reporting and
recordkeeping requirements.
(c) Exporters
Exporters of CBM, as for other class I controlled substances, must
submit information within 45 days after the end of the control period,
including the names and addresses of the exporter and the recipient of
the exports, the type and quantity of the controlled substances
exported, percentage which is used, recycled, or reclaimed, date/port
of export, amount exported to Article 5 countries, and documentation or
certification relating to purchaser's or importer's intent to transform
or destroy the controlled substance. Exporters of class I controlled
substances must also label, in the case of exports of used (including
recycled or reclaimed) controlled substance, bills of lading or
invoices, indicating that the controlled substance is used, recycled,
or reclaimed. See 40 CFR part 82, subpart A (Sec. 82.13) for the
complete reporting and recordkeeping requirements.
(d) Destroyers
Entities that destroy CBM, as with other class I controlled
substances, must submit a one-time report stating the destruction
unit's efficiency and the methods used to determine destruction
efficiency and to record the volume destroyed. Changes to these methods
must be reported within 60 days of the change. The report must also
include names of other regulations applicable to the destruction
process. Such entities must also provide the producer or importer from
whom they purchased or received the controlled substances with a
verification that controlled substances will be used in processes that
result in their destruction. Destroyers of class I controlled
substances must also report the names and quantities of class I
controlled substances destroyed for each control period within 45 days
of the end of the control period. See 40 CFR part 82, subpart A (Sec.
82.13) for the complete reporting and recordkeeping requirements.
(e) Transformers
Entities that transform CBM, as for other class I controlled
substances, must provide the producer or importer of the controlled
substances the IRS certification that the controlled substances are to
be used in processes resulting in their transformation, and report the
names and quantities of class I controlled substances transformed for
each control period within 45 days of

[[Page 42888]]

the end of the control period. See 40 CFR part 82, subpart A (Sec.
82.13) for the complete reporting and recordkeeping requirements.
(f) Transhipments and Heels
Entities that bring back a container with a heel of CBM to the
United States must report quarterly the amount brought into the United
States, certifying that the residual amount in each shipment is less
than 10% of the volume of the container and will remain in the
container and be included in a future shipment, be recovered and
transformed or destroyed, or be recovered for a non-emissive use. They
must also report on the final disposition of each shipment within 45
days of the end of the control period. Entities that transship a
controlled substance must maintain records that indicate that the
controlled substance shipment originated in a foreign country destined
for another foreign country, and does not enter interstate commerce
with the United States.
(g) Laboratory Essential Uses
CBM that is to be used in laboratory applications is exempted from
the ban in the same manner that all other Class I ODSs are exempted for
laboratory uses. Laboratory distributors who sell CBM under this
exemption are subject to the reporting requirements outlined in 40 CFR
part 82, subpart A (Sec. 82.13). These reporting requirements are as
follows: Laboratory distributors/suppliers must report quarterly the
quantity received of each class I controlled substance from each
producer or importer. Distributors must also keep on record
certifications from customers who purchase CBM (or any Class I ODS)
stating that the CBM will only be used in laboratory applications
defined in 40 CFR part 82, subpart A (Sec. 82.13), appendix G.
(Laboratory customers purchasing a controlled substance under the
global laboratory essential-use exemption must provide the producer,
importer or distributor with a one-time-per-year certification for each
controlled substance that the substance will only be used for
laboratory applications and not be resold or used in manufacturing).
Distributors must report quarterly the quantity of the controlled
substance purchased by each laboratory customer. If the controlled
substances are only sold as reference standards for calibrating
laboratory analytical equipment, the distributor may write a letter to
the EPA Administrator requesting permission to submit these reports
annually rather than quarterly. See 40 CFR part 82, subpart A (Sec.
82.13) for complete reporting and recordkeeping requirements.

V. What Other Stratospheric Protection Regulations Will Relate to CBM
Following Today's Action?

A regulation originally published on February 11, 1993 (58 FR 8136)
and amended at 60 FR 4020 (January 19, 1995) establishes requirements
pertaining to labeling of products containing or made with ozone-
depleting substances. The text of that regulation (as well as Fact
Sheets about it) can be found at the following Web site:
http://www.epa.gov/ozone/title6/labeling/labeling.html. The labeling
requirements apply to products manufactured with, containers of, and
products containing specific ozone-depleting substances pursuant to
section 611 of the CAA. Specifically, the regulations require products
that are manufactured with a process using a class I substance;
products containing a class I substance; and containers of a class I or
class II (hydrochlorofluorocarbons (HCFCs)) substance or mixture to
bear a ``clearly legible and conspicuous'' warning statement.
Manufacturers, distributors, wholesalers, and retailers of products
manufactured with, containers of, and products containing CBM are
therefore required to comply with the labeling requirements which would
become applicable to CBM one year after its final listing as a class I
ODS; See 40 CFR part 82, subpart E.

VI. Statutory and Executive Order Reviews

A. Executive Order 12866: Regulatory Planning and Review

Under Executive Order 12866 (58 FR 51735, October 4, 1993), the
Agency must determine whether this regulatory action is ``significant''
and therefore subject to OMB review and the requirements of the
Executive Order. The Order defines a ``significant'' regulatory action
as one that is likely to result in a rule that may:
(1) Have an annual effect on the economy of $100 million or more,
or adversely affect in a material way the economy, a sector of the
economy, productivity, competition, jobs, the environment, public
health or safety, or State, local, or tribal governments or
communities;
(2) Create a serious inconsistency or otherwise interfere with an
action taken or planned by another agency;
(3) Materially alter the budgetary impact of entitlements, grants,
user fees, or loan programs or the rights and obligations of recipients
thereof; or
(4) Raise novel legal or policy issues arising out of legal
mandates, the President's priorities, or the principles set forth in
the Executive Order.
It has been determined that this rule is not a ``significant
regulatory action'' under the terms of Executive Order 12866 and is
therefore not subject to OMB review.

B. Paperwork Reduction Act

The information collection requirements in this rule have been
approved by the Office of Management and Budget (OMB) (OMB Control
Number 2060-0170) under the Paperwork Reduction Act, 44 U.S.C. 3501 et
seq. An Information Collection Request (ICR) document has been prepared
by EPA (ICR No. 1432.22) and a copy may be obtained from Susan Auby by
mail at Collection Strategies Division; U.S. Environmental Protection
Agency (2822T); 1200 Pennsylvania Ave., NW., Washington, DC 20460, by
email at auby.susan @epa.gov, or by calling (202) 566-1672. A copy may
also be downloaded off the Internet at http://www.epa.gov/icr.
As explained in EPA's ICR document, EPA's Office of Air and
Radiation is revising the previously approved information collection by
the same title.\2\ Today's action imposes new recordkeeping and
reporting requirements associated with the production, import, export,
recycling, destruction, transhipment, and feedstock use of CBM.
Specifically, producers, importers, and exporters will be required to
submit to EPA quarterly reports of the quantity of CBM in each of their
transactions; they will also be required to report the quantity of CBM
transformed or destroyed. Producers, importers, and exporters of CBM
must also maintain records such as Customs entry forms, bills of
lading, sales records, and canceled checks to support their quarterly
reports. The quarterly reports may be faxed or mailed to EPA, where
they will be handled as confidential business information. EPA will
store the submitted information in a computerized database designed to
track production, import, and export balances and transfer activities.
EPA is currently exploring the possibility of having reports filed and
submitted to the Agency over a secure Web site. If

[[Page 42889]]

and when electronic reporting would occur, EPA would change its
guidance document and its ICR to indicate a change in burden hours. EPA
will use the information to ensure that the U.S. maintains compliance
with the Protocol requirements and to report annually to United Nations
Environment Programme the U.S. activity in CBM. EPA will store the
submitted information in a computer system designed to track
production, import, and export balances and transfer activities. EPA
estimates that the information collection will involve approximately
133 respondents: 2 producers, 2 exporters, 8 importers, 100 laboratory
certifiers, 8 transformers and destroyers, 6 essential use allowance
holders, 2 laboratory suppliers, and 5 laboratory suppliers (reference
standards). The total annual industry burden and cost are estimated at
2,580 hours and $201,350, of which $3,000 are annual operating and
maintenance (O&M) costs.
---------------------------------------------------------------------------

\2\ On March 5, 2001, the Office of Management and Budget (OMB)
approved EPA's request for the extension of approval of this ICR.
The request for extension was submitted by EPA on November 29, 2000.
With that approval, OMB stated that it ``understands that EPA is in
the process of developing several rules that would result in
revisions to this collection * * * EPA will need to revise this
collection as part of those rulemaking processes.'' This ICR
revision is one such revision.
---------------------------------------------------------------------------

Burden means the total time, effort, or financial resources
expended by persons to generate, maintain, retain, or disclose or
provide information to or for a Federal agency. This includes the time
needed to review instructions; develop, acquire, install, and utilize
technology and systems for the purposes of collecting, validating, and
verifying information, processing and maintaining information, and
disclosing and providing information; adjust the existing ways to
comply with any previously applicable instructions and requirements;
train personnel to be able to respond to a collection of information;
search data sources; complete and review the collection of information;
and transmit or otherwise disclose the information.
An Agency may not conduct or sponsor, and a person is not required
to respond to, a collection of information unless it displays a
currently valid OMB control number. The OMB control numbers for EPA's
regulations are listed in 40 CFR part 9 and 48 CFR chapter 15. Comments
were requested on the Agency's need for this information, the accuracy
of the provided burden estimates, and any suggested methods for
minimizing respondent burden, including through the use of automated
collection techniques. No comments were received.

C. Regulatory Flexibility Act

EPA has determined that it is not necessary to prepare a regulatory
flexibility analysis in connection with this final rule. EPA has also
determined that this rule will not have a significant economic impact
on a substantial number of small entities. For purposes of assessing
the impact of today's rule on small entities, small entities are
defined as: (1) A small business that is identified by the North
American Industry Classification System (NAICS) code, in the Table
below; (2) a small governmental jurisdiction that is a government of a
city, county, town, school district or special district with a
population of less than 50,000; and (3) a small organization that is
any not-for-profit enterprise which is independently owned and operated
and is not dominant in its field. The size standards described in this
section apply to all Small Business Administration (SBA) programs
unless otherwise specified. The size standards themselves are expressed
either in number of employees or annual receipts in millions of
dollars, unless otherwise specified. The number of employees or annual
receipts indicates the maximum allowed for a concern and its affiliates
to be considered small.

----------------------------------------------------------------------------------------------------------------
SIC small
business size
standard (in
Category SIC code NAICS code number of
employees or
millions of
dollars)
----------------------------------------------------------------------------------------------------------------
1. Industrial organic chemicals, NEC........ 2869............................... 325199 1,000
2. Pharmaceutical preparations.............. 2834............................... 325412 750
3. Pesticides and agricultural chemicals, 2879............................... 32532 500
NEC.
4. Chemicals and allied products, NEC....... 5169............................... 42269 100
5. Testing laboratories, except veterinary 8734............................... 54138 $5.0
testing labs.
6. Medical and diagnostic laboratories...... 8071............................... 6215 $5.0
7. Research and development in the physical, 8731 and 8733...................... 54171 $5.0
engineering and life sciences.
----------------------------------------------------------------------------------------------------------------

After considering the economic impacts of today's final rule on
small entities, EPA has concluded that this action will not have a
significant economic impact on a substantial number of small entities.
The only small entities that will be impacted by the recordkeeping and
reporting requirements of this rule are laboratories. We have
determined that about 100 laboratories (only a portion of which are
owned by small entities) will experience an annual estimated impact of
$7,688 due to the reporting and recordkeeping requirements described in
40 CFR part 82, subpart A (Sec. 82.13).
In addition to the recordkeeping and reporting requirements,
today's action bans the production and import of CBM. There are only 2
known producers of CBM in the United States. These are large,
multinational corporations and not small entities. In addition,
informal discussions with these producers indicate that virtually all
of their CBM production is for customers who transform CBM; this
production is not subject to the CBM phaseout implemented by today's
action.
Regarding import, EPA records indicate that during the years 1995-
1999 (the years for which data were available), 22 companies had
imported CBM during one or more years. Of these, 16 had imported CBM in
only one of the 5 years of record. Informal discussions with the
primary importer (responsible for 77% of the imported CBM) indicate
that 80-85% of their imports are for transformation. Thus, the impacts
of today's action on CBM importers will also be limited (providing that
import is from countries that are Parties to or in compliance with the
Beijing Amendments).
Although this final rule will not have a significant economic
impact on a substantial number of small entities, EPA nonetheless has
tried to reduce the impact of this rule on small entities. Laboratories
will only be required to certify purchases of CBM one time per year, in
which they must indicate their use of CBM will only be used for
laboratory or analytical purposes and identify the specific use to
which the substance will be put. This requirement

[[Page 42890]]

is to ensure proper use of exempted production and import and allow the
U.S. to report specific information to the Montreal Protocol under
Annex II of Decision VI/9. EPA received no comment on the NPRM (67 FR
65916, 10/29/02) regarding impact on laboratories.
EPA conducted outreach to consult with and notified the potentially
affected community of today's action. EPA sent letters on February 28,
2001, and again on April 25, 2000, to all importers for which addresses
could be found, as well as other identified entities that may be
impacted by this rule, notifying them of EPA's anticipated
implementation of the 1999 Beijing Amendments to the Montreal Protocol,
including the ban on production and import, and new recordkeeping and
reporting requirements. EPA received no adverse concern by any
recipient of the letters.

D. Unfunded Mandates Reform Act

Title II of the Unfunded Mandates Reform Act of 1995 (UMRA), Public
Law 104-4, establishes requirements for Federal agencies to assess the
effects of their regulatory actions on State, local, and tribal
governments and the private sector.
Under section 202 of the UMRA, EPA generally must prepare a written
statement, including a cost-benefit analysis, for proposed and final
rules with ``Federal mandates'' that may result in expenditures to
State, local, and tribal governments, in the aggregate, or to the
private sector, of $100 million or more in any one year. Before
promulgating an EPA rule for which a written statement is needed,
section 205 of the UMRA generally requires EPA to identify and consider
a reasonable number of regulatory alternatives and adopt the least
costly, most cost-effective or least burdensome alternative that
achieves the objectives of the rule. The provisions of section 205 do
not apply when they are inconsistent with applicable law. Moreover,
section 205 allows EPA to adopt an alternative other than the least
costly, most cost-effective or least burdensome alternative if the
Administrator publishes with the final rule an explanation why that
alternative was not adopted.
Before EPA establishes any regulatory requirements that may
significantly or uniquely affect small governments, including tribal
governments, it must have developed under section 203 of the UMRA a
small government agency plan. The plan must provide for notifying
potentially affected small governments, enabling officials of affected
small governments to have meaningful and timely input in the
development of EPA regulatory proposals with significant Federal
intergovernmental mandates, and informing, educating, and advising
small governments on compliance with the regulatory requirements.
EPA has determined that this rule does not contain a Federal
mandate that may result in expenditures of $100 million or more for
State, local, and tribal governments, in the aggregate, or the private
sector in any one year. Today's ban on production and import is
expected to have minimal economic impact because production and import
for feedstock uses (which represent the majority of current production
and import uses) are exempt from the ban. Furthermore, CBM use has been
largely curtailed by prior environmental and safety regulations in the
fire protection, explosion suppression, and solvent sectors. Therefore
the ban of CBM is not expected to significantly affect the regulated
community.
Based upon research and information available to EPA at this time,
EPA understands that the regulated community directly impacted by
today's action is restricted in size. Potentially regulated entities
include entities that produce, export, or import CBM; entities that use
CBM in a process that results in its transformation or destruction;
entities that are laboratory suppliers of CBM; and entities with
laboratory uses of CBM. For all of these entities, there would be new
recordkeeping and reporting requirements imposed by today's action, but
these are estimated to be minimal (approximately a total for the
industry of $200,000 per year; see VII.B. for explanation of this
estimate).
Thus, today's rule is not subject to the requirements of sections
202 or 205 of the UMRA. EPA has also determined that this rule contains
no regulatory requirements that might significantly or uniquely affect
small governments; therefore, we are not required to develop a plan
with regard to small governments under section 203.

E. Executive Order 13132: Federalism

Executive Order 13132, entitled ``Federalism'' (64 FR 43255, August
10, 1999), requires EPA to develop an accountable process to ensure
``meaningful and timely input by State and local officials in the
development of regulatory policies that have federalism implications.''
``Policies that have federalism implications'' is defined in the
Executive Order to include regulations that have ``substantial direct
effects on the States, on the relationship between the national
government and the States, or on the distribution of power and
responsibilities among the various levels of government.''
This final rule will not have federalism implications. It will not
have substantial direct effects on the States, on the relationship
between the national government and the States, or on the distribution
of power and responsibilities among the various levels of government,
as specified in Executive Order 13132.
Today's rule is expected to primarily affect private sector
entities that either produce, import, export, transform, or use or
supply CBM for laboratory purposes. EPA is not aware of any current
uses of CBM by public sector entities. Thus, Executive Order 13132 does
not apply to this rule.

F. Executive Order 13175: Consultation and Coordination with Indian
Tribal Governments

Executive Order 13175, entitled ``Consultation and Coordination
with Indian Tribal Governments'' (59 FR 22951, November 9, 2000),
requires EPA to develop an accountable process to ensure ``meaningful
and timely input by tribal officials in the development of regulatory
policies that have tribal implications.''
This final rule does not have tribal implications, as specified in
Executive Order 13175. It will not have substantial direct effects on
tribal governments, on the relationship between the Federal government
and Indian tribes, or on the distribution of power and responsibilities
between the Federal government and Indian tribes, as specified in
Executive Order 13175.
Today's rule is expected to primarily affect private sector
entities that either produce, import, export, transform, or use or
supply CBM for laboratory purposes. EPA is not aware of any current
uses of CBM by tribal governments or their communities. Thus, Executive
Order 13175 does not apply to this rule.
In the spirit of Executive Order 13175, and consistent with EPA
policy to promote communications between EPA and tribal governments,
EPA specifically solicited additional comment on this rule from tribal
officials. No comments were received.

G. Executive Order 13045: Protection of Children From Environmental
Health and Safety Risks

Executive Order 13045: ``Protection of Children from Environmental
Health Risks and Safety Risks'' (62 FR 19885, April 23, 1997) applies
to any rule that: (1) Is determined to be ``economically significant''
as defined under Executive Order 12866, and (2) concerns an

[[Page 42891]]

environmental health or safety risk that EPA has reason to believe may
have a disproportionate effect on children. If the regulatory action
meets both criteria, the Agency must evaluate the environmental health
or safety effects of the planned rule on children, and explain why the
planned regulation is preferable to other potentially effective and
reasonably feasible alternatives considered by the Agency.
EPA interprets Executive Order 13045 as applying only to those
regulatory actions that are based on health or safety risks, such that
the analysis required under section 5-501 of the Order has the
potential to influence the regulation.
This final rule is not subject to the Executive Order because it is
not economically significant as defined in Executive Order 12866, and
because the Agency does not have reason to believe the environmental
health or safety risks addressed by this action present a
disproportionate risk to children. This rule implements an obligation
of the United States to implement fully the provisions of the Montreal
Protocol and is not directly based on health or safety risks.

H. Executive Order 13211: Action That Significanty Energy Supply,
Distribution, or Use

This rule is not subject to Executive Order 13211, ``Actions
Concerning Regulations that Significantly Affect Energy Supply,
Distribution, or Use,'' (66 FR 28355 (May 22, 2001)) because it is not
a significant regulatory action under Executive Order 12866.

I. National Technology Transfer Advancement Act

As noted in the proposed rule, section 12(d) of the National
Technology Transfer and Advancement Act of 1995 (``NTTAA''), Public Law
104-113, section 12(d) (15 U.S.C. 272 note) directs EPA to use
voluntary consensus standards in its regulatory activities unless to do
so would be inconsistent with applicable law or otherwise impractical.
Voluntary consensus standards are technical standards (e.g., materials
specifications, test methods, sampling procedures, and business
practices) that are developed or adopted by voluntary consensus
standards bodies. The NTTAA directs EPA to provide Congress, through
OMB, explanations when the Agency decides not to use available and
applicable voluntary consensus standards. This action does not involve
technical standards. Therefore, EPA did not consider the use of any
voluntary consensus standards.

J. Congressional Review Act

The Congressional Review Act, 5 U.S.C. 801 et seq., as added by the
Small Business Regulatory Enforcement Fairness Act of 1996, generally
provides that before a rule may take effect, the agency promulgating
the rule must submit a rule report, which includes a copy of the rule,
to each House of the Congress and to the Comptroller General of the
United States. EPA will submit a report containing this rule and other
required information to the U.S. Senate, the U.S. House of
Representatives, and the Comptroller General of the United States prior
to publication of the rule in the Federal Register. A major rule cannot
take effect until 60 days after it is published in the Federal
Register. This action is not a ``major rule'' as defined by 5 U.S.C.
804(2). This rule will be effective October 16, 2003.

List of Subjects in 40 CFR Part 82

Environmental protection, Administrative practice and procedure,
Air pollution control, Chemicals, Exports, Government procurement,
Imports, Labeling, Reporting and recordkeeping requirements .

Dated: July 11, 2003.
Christine Todd Whitman,
Acting Administrator.

? For reasons set out in the preamble, 40 CFR part 82 is amended as
follows:

PART 82--PROTECTION OF STRATOSPHERIC OZONE

? 1. The authority citation for part 82 continues to read as follows:

Authority: 42 U.S.C. 7414, 7601, 7671-7671q.

Subpart A--Production and Consumption Controls

? 2. Section 82.3 is amended by:
? a. Adding in alphabetical order the definition of Beijing Amendments.
? b. Revising the last sentence in the definition of Controlled
substances.
The revision and addition read as follows:

Sec. 82.3 Definitions.

* * * * *
Beijing Amendments means the Montreal Protocol, as amended at the
Eleventh Meeting of the Parties to the Montreal Protocol in Beijing in
1999.
* * * * *
Controlled substance * * * Class I substances are further divided
into eight groups, Group I, Group II, Group III, Group IV, Group V,
Group VI, Group VII, and Group VIII, as set forth in appendix A to this
subpart.
* * * * *

? 3. Section 82.4 is amended by:

? a. Revising the first sentence of paragraph (b),
? b. Revising the first sentence of paragraph (d),
? c. Adding paragraph (l)(5).
The revisions and addition read as follows:

Sec. 82.4 Prohibitions.

* * * * *
(b) Effective January 1, 1996, for any class I, Group I, Group II,
Group III, Group IV, Group V, or Group VII controlled substances, and
effective January 1, 2005, for any class I, Group VI controlled
substance, and effective August 18, 2003, for any class I, Group VIII
controlled substance, no person may produce, at any time in any control
period, (except that are transformed or destroyed domestically or by a
person of another Party) in excess of the amount of conferred
unexpended essential-use allowances or exemptions under this section,
or the amount of unexpended Article 5 allowances as allocated under
Sec. 82.9 for that substance held by that person under the authority
of this subpart at that time for that control period. ***
* * * * *
(d) Effective January 1, 1996, for any class I, Group I, Group II,
Group III, Group IV, Group V, or Group VII controlled substances, and
effective January 1, 2005, for any class I, Group VI controlled
substance, and effective August 18, 2003, for any class I, Group VIII
controlled substance, no person may import (except for transhipments or
heels), at any time in any control period, (except for controlled
substances that are transformed or destroyed) in excess of the amount
of unexpended essential-use allowances or exemptions as allocated under
this section for that substance held by that person under the authority
of this subpart at that time for that control period. * * *
* * * * *
(l) * * *
(5) Import or export any quantity of a controlled substance listed
in Class I, Group VIII, in appendix A to this subpart, from or to any
foreign state not Party to the Beijing Amendments (as noted in appendix
C, Annex 1, to this subpart), unless that foreign state is complying
with the Beijing Amendments (as noted in appendix C, Annex 2, to this
subpart).
* * * * *

? 4. Section 82.13 is amended by:
? a. Revising paragraph (a).
? b. Revising paragraph (f)(1) introductory text.
The revisions read as follows:

[[Page 42892]]

Sec. 82.13 Recordkeeping and reporting requirements.

(a) Unless otherwise specified, the recordkeeping and reporting
requirements set forth in this section take effect on January 1, 1995.
For class I, Group VIII controlled substances, the recordkeeping and
reporting requirements set forth in this section take effect on August
18, 2003.
* * * * *
(f) * * *
(1) Within 120 days of May 10, 1995, or within 120 days of the date
that a producer first produces a class I controlled substance,
whichever is later, and within 120 days of July 18, 2003 for class I,
Group VIII controlled substances, every producer who has not already
done so must submit to the Administrator a report describing:
* * * * *

? 5. Appendix A to subpart A is amended by adding paragraph H to read as
follows:

Appendix A to Subpart A of Part 82--Class 1 Controlled Substances

Class 1 controlled substances ODP
* * * * *
H. Group VIII:
CH2BrCl (Chlorobromomethane 0.12

? 6. Appendix C to subpart A is revised to read as follows:

Appendix C to Subpart A of Part 82--Parties to the Montreal Protocol,
and Nations Complying With, But Not Parties to, the Protocol

Annex 1 to Appendix C of Subpart A--Parties to the Montreal Protocol
(as of April 11, 2003)

The check mark [Ö]
means the particular country ratified the
Protocol or the specific Amendment package. Amendment packages are
identified by the name of the city where the amendment package was
negotiated and agreed. Updated lists of Parties to the Protocol and the
Amendments can be located at: www.unep.org/ozone/ratif.shtml.

----------------------------------------------------------------------------------------------------------------
Montreal London Copenhagen Montreal Beijing
Foreign State protocol amendment amendments amendments amendments
----------------------------------------------------------------------------------------------------------------
Albania................................... Ö ............ ............ ............ ............
Algeria................................... Ö
Ö
Ö ............ ............
Angola.................................... Ö
............ ............ ............ ............
Antigua and Barbuda....................... Ö
Ö
Ö Ö ............
Argentina................................. Ö
Ö
Ö Ö ............
Armenia................................... Ö
............ ............ ............ ............
Australia................................. Ö
Ö
Ö Ö ............
Austria................................... Ö
Ö
Ö Ö ............
Azerbaijan................................ Ö
Ö
Ö Ö ............
Bahamas................................... Ö
Ö
Ö ............ ............
Bahrain................................... Ö
Ö
Ö Ö ............
Bangladesh................................ Ö
Ö
Ö Ö ............
Barbados.................................. Ö
Ö
Ö Ö Ö
Belarus................................... Ö
Ö
............ ............ ............
Belgium................................... Ö
Ö
Ö ............ ............
Belize.................................... Ö
Ö
Ö ............ ............
Benin..................................... Ö
Ö
Ö ............ ............
Bolivia................................... Ö
Ö
Ö Ö ............
Bosnia and Herzegovina.................... Ö
............ ............ ............ ............
Botswana.................................. Ö
Ö
Ö ............ ............
Brazil.................................... Ö
Ö
Ö ............ ............
Brunei Darussalam......................... Ö
............ ............ ............ ............
Bulgaria.................................. Ö
Ö
Ö Ö Ö
Burkina Faso.............................. Ö
Ö
Ö Ö Ö
Burundi................................... Ö
Ö
Ö Ö Ö
Cambodia.................................. Ö
............ ............ ............ ............
Cameroon.................................. Ö
Ö
Ö ............ ............
Canada.................................... Ö
Ö
Ö Ö Ö
Cape Verde................................ Ö
Ö
Ö Ö ............
Central African Republic.................. Ö
............ ............ ............ ............
Chad...................................... Ö
Ö
Ö Ö ............
Chile..................................... Ö
Ö
Ö Ö Ö
China..................................... Ö
Ö
............ ............ ............
Colombia.................................. Ö
Ö
Ö ............ ............
Comoros................................... Ö
Ö
Ö Ö Ö
Congo..................................... Ö
Ö
Ö Ö Ö
Congo, Democratic Republic of............. Ö
Ö
Ö ............ ............
Costa Rica................................ Ö
Ö
Ö ............ ............
Cote d'Ivoire............................. Ö
Ö
............ ............ ............
Croatia................................... Ö
Ö
Ö Ö Ö
Cuba...................................... Ö
Ö
Ö ............ ............
Cyprus.................................... Ö
Ö
............ ............ ............
Czech Republic............................ Ö
Ö
Ö Ö Ö
Denmark................................... Ö
Ö
Ö ............ ............
Djibouti.................................. Ö
Ö
Ö Ö ............
Dominica.................................. Ö
Ö
............ ............ ............
Dominican Republic........................ Ö
Ö
Ö ............ ............
Ecuador................................... Ö
Ö
Ö ............ ............
Egypt..................................... Ö
Ö
Ö Ö ............
El Salvador............................... Ö
Ö
Ö Ö ............
Equatorial Guinea......................... ............ ............ ............ ............ ............
Estonia................................... Ö
Ö
Ö Ö ............

[[Page 42893]]

Ethiopia.................................. Ö
............ ............ ............ ............
European Community........................ Ö
Ö
Ö Ö Ö
Federated States of Micronesia............ Ö
Ö
Ö Ö Ö
Fiji...................................... Ö
Ö
Ö ............ ............
Finland................................... Ö
Ö
Ö Ö Ö
France.................................... Ö
Ö
Ö ............ ............
Gabon..................................... Ö
Ö
Ö Ö Ö
Gambia.................................... Ö
Ö
............ ............ ............
Georgia................................... Ö
Ö
Ö Ö ............
Germany................................... Ö
Ö
Ö Ö Ö
Ghana..................................... Ö
Ö
Ö ............ ............
Greece.................................... Ö
Ö
Ö ............ ............
Grenada................................... Ö
Ö
Ö Ö ............
Guatemala................................. Ö
Ö
Ö Ö Ö
Guinea.................................... Ö
Ö
............ ............ ............
Guinea Bissau............................. Ö
Ö
Ö Ö Ö
Guyana.................................... Ö
Ö
Ö Ö ............
Haiti..................................... Ö
Ö
Ö Ö ............
Honduras.................................. Ö
Ö
Ö ............ ............
Hungary................................... Ö
Ö
Ö Ö Ö
Iceland................................... Ö
Ö
Ö Ö ............
India..................................... Ö
Ö
Ö Ö Ö
Indonesia................................. Ö
Ö
Ö ............ ............
Iran, Islamic............................. Ö
Ö
Ö Ö ............
Ireland................................... Ö
Ö
Ö ............ ............
Israel.................................... Ö
Ö
Ö ............ ............
Italy..................................... Ö
Ö
Ö Ö ............
Jamaica................................... Ö
Ö
Ö ............ ............
Japan..................................... Ö
Ö
Ö Ö Ö
Jordan.................................... Ö
Ö
Ö Ö Ö
Kazakhstan................................ Ö
Ö
............ ............ ............
Kenya..................................... Ö
Ö
Ö Ö ............
Kiribati.................................. Ö
............ ............ ............ ............
Korea, Democratic People's Republic of.... Ö
Ö
Ö Ö Ö
Korea, Republic of........................ Ö
Ö
Ö Ö ............
Kuwait.................................... Ö
Ö
Ö ............ ............
Kyrgyzstan................................ Ö
............ ............ ............ ............
Lao, People's Democratic Republic......... Ö
............ ............ ............ ............
Latvia.................................... Ö
Ö
Ö Ö ............
Lebanon................................... Ö
Ö
Ö Ö ............
Lesotho................................... Ö
............ ............ ............ ............
Liberia................................... Ö
Ö
Ö ............ ............
Libyan Arab Jamahiriya.................... Ö
Ö
............ ............ ............
Liechtenstein............................. Ö
Ö
Ö ............ ............
Lithuania................................. Ö
Ö
Ö ............ ............
Luxembourg................................ Ö
Ö
Ö Ö Ö
Madagascar................................ Ö
Ö
Ö Ö Ö
Malawi.................................... Ö
Ö
Ö ............ ............
Malaysia.................................. Ö
Ö
Ö Ö Ö
Maldives.................................. Ö
Ö
Ö Ö Ö
Mali...................................... Ö
Ö
Ö Ö ............
Malta..................................... Ö
Ö
............ ............ ............
Marshall Islands.......................... Ö
Ö
Ö Ö ............
Mauritania................................ Ö
............ ............ ............ ............
Mauritius................................. Ö
Ö
Ö Ö Ö
Mexico.................................... Ö
Ö
Ö ............ ............
Moldova................................... Ö
Ö
Ö ............ ............
Monaco.................................... Ö
Ö
Ö Ö Ö
Mongolia.................................. Ö
Ö
Ö Ö ............
Morocco................................... Ö
Ö
Ö ............ ............
Mozambique................................ Ö
Ö
Ö ............ ............
Myanmar................................... Ö
Ö
............ ............ ............
Namibia................................... Ö
Ö
............ ............ ............
Nauru..................................... Ö
............ ............ ............ ............
Nepal..................................... Ö
Ö
............ ............ ............
Netherlands............................... Ö
Ö
Ö Ö Ö
New Zealand............................... Ö
Ö
Ö Ö Ö
Nicaragua................................. Ö
Ö
Ö ............ ............
Niger..................................... Ö
Ö
Ö Ö ............
Nigeria................................... Ö
Ö
Ö Ö ............
Norway.................................... Ö
Ö
Ö Ö Ö
Oman...................................... Ö
Ö
Ö ............ ............
Pakistan.................................. Ö
Ö
Ö ............ ............

[[Page 42894]]

Palau..................................... Ö
Ö
Ö Ö Ö
Panama.................................... Ö
Ö
Ö Ö Ö
Papua New Guinea.......................... Ö
Ö
............ ............ ............
Paraguay.................................. Ö
Ö
Ö Ö ............
Peru...................................... Ö
Ö
Ö ............ ............
Philippines............................... Ö
Ö
Ö ............ ............
Poland.................................... Ö
Ö
Ö Ö ............
Portugal.................................. Ö
Ö
Ö ............ ............
Qatar..................................... Ö
Ö
Ö ............ ............
Romania................................... Ö
Ö
Ö Ö ............
Russian Federation........................ Ö
Ö
............ ............ ............
Rwanda.................................... Ö
............ ............ ............ ............
Saint Kitts & Nevis....................... Ö
Ö
Ö Ö ............
Saint Lucia............................... Ö
Ö
Ö Ö Ö
Saint Vincent and the Grenadines.......... Ö
Ö
Ö ............ ............
Samoa..................................... Ö
Ö
Ö Ö Ö
Sao Tome and Principe..................... Ö
Ö
Ö Ö Ö
Saudi Arabia.............................. Ö
Ö
Ö ............ ............
Senegal................................... Ö
Ö
Ö Ö ............
Seychelles................................ Ö
Ö
Ö Ö Ö
Sierra Leone.............................. Ö
Ö
Ö Ö Ö
Singapore................................. Ö
Ö
Ö Ö ............
Slovakia.................................. Ö
Ö
Ö Ö Ö
Slovenia.................................. Ö
Ö
Ö Ö Ö
Solomon Island............................ Ö
Ö
Ö Ö ............
Somalia................................... Ö
Ö
Ö Ö Ö
South Africa.............................. Ö
Ö
Ö ............ ............
Spain..................................... Ö
Ö
Ö Ö Ö
Sri Lanka................................. Ö
Ö
Ö Ö Ö
Sudan..................................... Ö
Ö
Ö ............ ............
Suriname.................................. Ö
............ ............ ............ ............
Swaziland................................. Ö
............ ............ ............ ............
Sweden.................................... Ö
Ö
Ö Ö Ö
Switzerland............................... Ö
Ö
Ö Ö Ö
Syrian Arab Republic...................... Ö
Ö
Ö Ö ............
Tajikistan................................ Ö
Ö
............ ............ ............
Tanzania, United Republic of.............. Ö
Ö
Ö Ö Ö
Thailand.................................. Ö
Ö
Ö ............ ............
The Former Yugoslav Republic of Macedonia. Ö
Ö
Ö Ö Ö
Togo...................................... Ö
Ö
Ö Ö Ö
Tonga..................................... Ö
............ ............ ............ ............
Trinidad and Tobago....................... Ö
Ö
Ö Ö ............
Tunisia................................... Ö
Ö
Ö Ö ............
Turkey.................................... Ö
Ö
Ö ............ ............
Turkmenistan.............................. Ö
Ö
............ ............ ............
Tuvalu.................................... Ö
Ö
Ö Ö ............
Uganda.................................... Ö
Ö
Ö Ö ............
Ukraine................................... Ö
Ö
Ö ............ ............
United Arab Emirates...................... Ö
............ ............ ............ ............
United Kingdom............................ Ö
Ö
Ö Ö Ö
United States of America.................. Ö
Ö
Ö ............ ............
Uruguay................................... Ö
Ö
Ö Ö ............
Uzbekistan................................ Ö
Ö
Ö ............ ............
Vanuatu................................... Ö
Ö
Ö ............ ............
Venezuela................................. Ö
Ö
Ö Ö ............
Viet Nam.................................. Ö
Ö
Ö ............ ............
Yemen..................................... Ö
Ö
Ö Ö ............
Yugoslavia................................ Ö
............ ............ ............ ............
Zambia.................................... Ö
Ö
............ ............ ............
Zimbabwe.................................. Ö
Ö
Ö ............ ............
----------------------------------------------------------------------------------------------------------------

Annex 2 to Appendix C of Subpart A--Nations Complying With, But Not
Parties to, the Protocol [Reserved]

? 7. Appendix F to subpart A is amended by:
? a. Removing entries F and G,
? b. Under A. Class I: by adding entries 6, 7, and 8.
The additions read as follows:

Appendix F to Subpart A--Listing of Ozone Depleting Chemicals

[[Page 42895]]

----------------------------------------------------------------------------------------------------------------
Controlled substance ODP AT L CLP BLP
----------------------------------------------------------------------------------------------------------------
A. Class I

* * * * * * *
6. Group VI:
CH3Br-Bromomethane (Methyl Bromide)..... 0.7 ........... [Reserved].................... .........
7. Group VII:
CHFBr₂-................................. 1.00 ........... [Reserved].................... .........
CHF₂Br-(HBFC-22B1)...................... 0.74 ........... [Reserved].................... .........
CH₂FBr.................................. 0.73 ........... [Reserved].................... .........
C₂HFBr₄................................. 0.3-0.8 ........... [Reserved].................... .........
C₂HF₂Br₃................................ 0.5-1.8 ........... [Reserved].................... .........
C₂HF₃Br₂................................ 0.4-16 ........... [Reserved].................... .........
C₂HF₄Br................................. 0.7-1.2 ........... [Reserved].................... .........
C₂H₂FBr₃................................ 0.1-1.1 ........... [Reserved].................... .........
C₂H₂F₂Br₂............................... 0.2-1.5 ........... [Reserved].................... .........
C₂H₂F₃Br................................ 0.7-1.6 ........... [Reserved].................... .........
C₂H₃FBr₂................................ 0.1-1.7 ........... [Reserved].................... .........
C₂H₃F₂Br................................ 0.2-1.1 ........... [Reserved].................... .........
C₂H₄FBr................................. 0.07-0.1 ........... [Reserved].................... .........
C₃HFBr₆................................. 0.3-1.5 ........... [Reserved].................... .........
C₃HF₂Br₅................................ 0.2-1.9 ........... [Reserved].................... .........
C₃HF₃Br₄................................ 0.3-1.8 ........... [Reserved].................... .........
C₃HF₄Br₃................................ 0.5-2.2 ........... [Reserved].................... .........
C₃HF₅Br₂................................ 0.9-2.0 ........... [Reserved].................... .........
C₃HF₆Br................................. 0.7-3.3 ........... [Reserved].................... .........
C₃H₂FBr₅................................ 0.1-1.9 ........... [Reserved].................... .........
C₃H₂F₂Br₄............................... 0.2-2.1 ........... [Reserved].................... .........
C₃H₂F₃Br₃............................... 0.2-5.6 ........... [Reserved].................... .........
C₃H₂F₄Br₂............................... 0.3-7.5 ........... [Reserved].................... .........
C₃H₂F₅Br................................ 0.9-1.4 ........... [Reserved].................... .........
C₃H₃FBR₄................................ 0.08-1.9 ........... [Reserved].................... .........
C₃H₃F₂Br₃............................... 0.1-3.1 ........... [Reserved].................... .........
C₃H₃F₃Br₂............................... 0.1-2.5 ........... [Reserved].................... .........
C₃H₃F₄Br................................ 0.3-4.4 ........... [Reserved].................... .........
C₃H₄FBr₃................................ 0.03-0.3 ........... [Reserved].................... .........
C₃H₄F₂Br₂............................... 0.1-1.0 ........... [Reserved].................... .........
C₃H₄F₃Br................................ 0.07-0.8 ........... [Reserved].................... .........
C₃H₅FBr₂................................ 0.04-0.4 ........... [Reserved].................... .........
C₃H₅F₂Br................................ 0.07-0.8 ........... [Reserved].................... .........
C₃H₆FB.................................. 0.02-0.7 ........... [Reserved].................... .........
8. Group VIII:
CH₂BrCl (Chlorobromomethane)............ 0.12 ........... [Reserved].................... .........
----------------------------------------------------------------------------------------------------------------

[FR Doc. 03-18154 Filed 7-17-03; 8:45 am]
BILLING CODE 6560-50-U

Notices For
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994

Protection of Stratospheric Ozone: Phaseout of Chlorobromomethane Production and Consumption

Local Navigation